Raise your Query

Hi! Simply click below and type your query.

Our experts will reply you very soon.

Need Help? Chat with us
Kapy Pharmaceutical

Emcef-S 750 Injection Supplier

Emcef-S 750 Injection
Business Type Supplier, Retailer
Composition of Product Ceftriaxone 500 mg + Sulbactum 250 mg
Pack Size 750 mg
Pack Type Vial with SWFI
Click to view more

Preferred Buyer From

Location Worldwide

Product Details

Therapeutic Classification
Antibiotic
Form
Injection
Storage
store in a cool place

Ceftriaxone 500mg + Sulbactam 250mg Salt Information :

Side Effects of Ceftriaxone 500mg + Sulbactam 250mg:
Superinfection; anaphylaxis; diarrhoea; local reactions; blood dyscrasias; rash, fever, pruritus; elevated transaminases and alkaline phosphatase. GI effects; pseudomembranous colitis; hematologic effects; hypersensitivity reactions; CNS disturbances; hypertension; chest pain; edema; moniliasis; rhinitis; dyspnea; hypotension; ileus; syncope; local Inj site reactions; rigors. Potentially Fatal: Pseudomembranous colitis; nephrotoxicity.

Drug Interactions of Ceftriaxone 500mg + Sulbactam 250mg:
Probenecid; aminoglycosides; vecuronium, methotrexate; oral anticoagulants; heparin. Potentially Fatal: Disulfiram-like reaction with alcohol. Nephrotoxicity with aminoglycosides and furosemide.

Contraindications of Ceftriaxone 500mg + Sulbactam 250mg:
Hypersensitivity to cephalosporins and β-lactamase inhibitors.

Mechanism of Action of Ceftriaxone 500mg + Sulbactam 250mg:
Ceftriaxone interferes with the biosynthesis of the peptidoglycan component of the bacterial cell way by binding to and inactivating penicllin-binding proteins (PBPs). Tazobactam is a penicillanic acid sulfone derivative with β-lactamase inhibitory properties. It enhances the activity of β-lactam antibacterials against β-lactamase-producing bacteria. Distribution: Ceftriaxone: 98% bound to plasma proteins; crosses the blood brain barrier. Tazobactam: About 30% bound to plasma proteins; widely distributed to tissues and body fluids. Excretion: Ceftriaxone: Elimination half-life is about 8.7 hr; 33-67% removed as unchanged drug. Tazobactam: Removed mainly via kidneys with 80% of an administered dose as unchanged drug.

Special Precautions for Ceftriaxone 500mg + Sulbactam 250mg:
History of penicillin allergy; lactation. Consider possibility of pseudomembranous colitis in patients who present with diarrhoea subsequent to the admin of antibacterial agents. Monitor prothrombin time in patients with impaired vit K synthesis or low vit K stores during treatment. Prolonged treatment may result in overgrowth of nonsusceptible organisms. Caution in patients with a history of GI disease, especially colitis. Discontinue treatment in patients who develop signs/symptoms suggestive of gallbladder disease. Not to be used in hyperbilirubinemic neonates, especially prematures.

Read More...

Yes! I am interested

Looking for "Emcef-S 750 Injection" ?

Explore More Products